ARNTL2, aryl hydrocarbon receptor nuclear translocator like 2, 56938
N. diseases: 41; N. variants: 11
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
12 | 27400936 | intron variant | C/T | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
12 | 27400808 | intron variant | A/C | snv | 0.19 | 0.13 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
12 | 27400174 | intron variant | A/T | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
12 | 27392427 | intron variant | C/T | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
12 | 27402157 | intron variant | A/G | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
12 | 27398316 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||||
|
12 | 27369833 | intron variant | G/A | snv | 0.55 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.882 | 0.080 | 12 | 27363909 | intron variant | T/G | snv | 0.29 |
|
Chemically-Induced Disorders; Mental Disorders | 0.030 | 1.000 | 3 | 2010 | 2015 | |||||||
|
0.807 | 0.200 | 12 | 27348173 | intron variant | G/A | snv | 0.43 |
|
Chemically-Induced Disorders; Mental Disorders | 0.030 | 1.000 | 3 | 2010 | 2015 | |||||||
|
0.882 | 0.080 | 12 | 27402904 | intron variant | C/T | snv | 0.37 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2010 | 2012 | |||||||
|
0.882 | 0.080 | 12 | 27402904 | intron variant | C/T | snv | 0.37 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.080 | 12 | 27402904 | intron variant | C/T | snv | 0.37 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.080 | 12 | 27402904 | intron variant | C/T | snv | 0.37 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.160 | 12 | 27402853 | intron variant | T/C | snv | 0.37 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.160 | 12 | 27402853 | intron variant | T/C | snv | 0.37 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.882 | 0.160 | 12 | 27402853 | intron variant | T/C | snv | 0.37 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.882 | 0.080 | 12 | 27363909 | intron variant | T/G | snv | 0.29 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.080 | 12 | 27363909 | intron variant | T/G | snv | 0.29 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.200 | 12 | 27348173 | intron variant | G/A | snv | 0.43 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.200 | 12 | 27348173 | intron variant | G/A | snv | 0.43 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.807 | 0.200 | 12 | 27348173 | intron variant | G/A | snv | 0.43 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.807 | 0.200 | 12 | 27348173 | intron variant | G/A | snv | 0.43 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.200 | 12 | 27348173 | intron variant | G/A | snv | 0.43 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 |